ID

14188

Description

Effect of Symbicort on GR Localisation in Asthma; ODM derived from: https://clinicaltrials.gov/show/NCT00159263

Link

https://clinicaltrials.gov/show/NCT00159263

Keywords

Versions (1)
  1. 4/4/16 4/4/16 -
Copyright Holder

CC BY-NC 3.0

Uploaded on

April 4, 2016

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Asthma NCT00159263

English

Eligibility Asthma NCT00159263

1 forms  
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00159263
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with mild steroid-naïve asthma (ats criteria) of either sex with fev1 >70 % pred
Description

steroid-naïve asthma

Data type

boolean

Alias
UMLS CUI [1,1]
C0004096
UMLS CUI [1,2]
C0038317
UMLS CUI [1,3]
C0919936
UMLS CUI [2]
C0748133
able to produce sputum after sputum induction
Description

sputum

Data type

boolean

Alias
UMLS CUI [1]
C0038056
exhaled no (flow 50 ml/s) ≥ 20 ppb
Description

exhaled no

Data type

boolean

written informed consent
Description

written informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
current upper respiratory tract infections
Description

comorbidity

Data type

boolean

Alias
UMLS CUI [1]
C0009488
use of inhaled and/or oral gcs within 4 weeks prior to visit 1
Description

steroid

Data type

boolean

Alias
UMLS CUI [1]
C0038317
treatment with antileukotrienes, theophylline, tiotropium and ipratropium within 2 weeks prior to screening visit
Description

antileukotrienes, theophylline, tiotropium and ipratropium

Data type

boolean

Alias
UMLS CUI [1,1]
C0039771
UMLS CUI [1,2]
C0040223
UMLS CUI [2,1]
C1306772
UMLS CUI [2,2]
C0040223
UMLS CUI [3,1]
C0700580
UMLS CUI [3,2]
C0040223
hypersensitivity to any of the investigational drugs or lactose
Description

hypersensitivity to any of the investigational drugs or lactose

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0022949
use of any -blocking agent (including eye-drops)
Description

use of any -blocking agent (including eye-drops)

Data type

boolean

women who are pregnant, breast-feeding or planning a pregnancy during the study. women must be postmenopausal (at least one year must have passed after the last menstruation), surgically sterile or using acceptable contraceptives, as judged by the investigator
Description

pregnancy, lactation, contraception, postmenopausal

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0700589
UMLS CUI [4]
C0232970
any significant disease or disorder (e.g. cardiovascular, pulmonary (other than asthma), gastrointestinal, liver, renal, neurological, musculoskeletal, endocrine, metabolic, malignant, psychiatric, major physical impairment) which, in the opinion of the investigator, may either put the subject at risk because of participation in the study, or may influence the results of the study, or the subjects ability to participate in the study
Description

comorbidity limiting study participation

Data type

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
inability to tolerate temporary withdrawal of bronchodilatory therapy
Description

inability to tolerate temporary withdrawal of bronchodilatory therapy

Data type

boolean

Alias
UMLS CUI [1,1]
C0006280
UMLS CUI [1,2]
C2349954
UMLS CUI [1,3]
C0231197
subjects not considered capable, as judged by the investigator, of following instructions of the study, e.g. because of a history of alcohol or drug abuse or any other reason
Description

comorbidity limiting compliance

Data type

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
previous randomization in this study
Description

previous randomization in this study

Data type

boolean

Alias
UMLS CUI [1,1]
C0034656
UMLS CUI [1,2]
C0205156
Back to the top of the page

Similar models

Eligibility Asthma NCT00159263

1 forms
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00159263
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
steroid-naïve asthma
Item
patients with mild steroid-naïve asthma (ats criteria) of either sex with fev1 >70 % pred
boolean
C0004096 (UMLS CUI [1,1])
C0038317 (UMLS CUI [1,2])
C0919936 (UMLS CUI [1,3])
C0748133 (UMLS CUI [2])
sputum
Item
able to produce sputum after sputum induction
boolean
C0038056 (UMLS CUI [1])
exhaled no
Item
exhaled no (flow 50 ml/s) ≥ 20 ppb
boolean
written informed consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
comorbidity
Item
current upper respiratory tract infections
boolean
C0009488 (UMLS CUI [1])
steroid
Item
use of inhaled and/or oral gcs within 4 weeks prior to visit 1
boolean
C0038317 (UMLS CUI [1])
antileukotrienes, theophylline, tiotropium and ipratropium
Item
treatment with antileukotrienes, theophylline, tiotropium and ipratropium within 2 weeks prior to screening visit
boolean
C0039771 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
C1306772 (UMLS CUI [2,1])
C0040223 (UMLS CUI [2,2])
C0700580 (UMLS CUI [3,1])
C0040223 (UMLS CUI [3,2])
hypersensitivity to any of the investigational drugs or lactose
Item
hypersensitivity to any of the investigational drugs or lactose
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0022949 (UMLS CUI [2,2])
use of any -blocking agent (including eye-drops)
Item
use of any -blocking agent (including eye-drops)
boolean
pregnancy, lactation, contraception, postmenopausal
Item
women who are pregnant, breast-feeding or planning a pregnancy during the study. women must be postmenopausal (at least one year must have passed after the last menstruation), surgically sterile or using acceptable contraceptives, as judged by the investigator
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0700589 (UMLS CUI [3])
C0232970 (UMLS CUI [4])
comorbidity limiting study participation
Item
any significant disease or disorder (e.g. cardiovascular, pulmonary (other than asthma), gastrointestinal, liver, renal, neurological, musculoskeletal, endocrine, metabolic, malignant, psychiatric, major physical impairment) which, in the opinion of the investigator, may either put the subject at risk because of participation in the study, or may influence the results of the study, or the subjects ability to participate in the study
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
inability to tolerate temporary withdrawal of bronchodilatory therapy
Item
inability to tolerate temporary withdrawal of bronchodilatory therapy
boolean
C0006280 (UMLS CUI [1,1])
C2349954 (UMLS CUI [1,2])
C0231197 (UMLS CUI [1,3])
comorbidity limiting compliance
Item
subjects not considered capable, as judged by the investigator, of following instructions of the study, e.g. because of a history of alcohol or drug abuse or any other reason
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
previous randomization in this study
Item
previous randomization in this study
boolean
C0034656 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial